Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

about

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

Item

http://www.wikidata.org/entity/Q52597961

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

@en

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

@nl

type

Item

label

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

@en

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

@nl

prefLabel

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

@en

Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.

@nl

P1476

Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels

@en

P2093

Anuradha Kumar

http://www.w3.org/2001/XMLSchema#string

Garrett C Moraski

http://www.w3.org/2001/XMLSchema#string

Julie V Early

http://www.w3.org/2001/XMLSchema#string

Marvin J Miller

http://www.w3.org/2001/XMLSchema#string

Philip A Hipskind

http://www.w3.org/2001/XMLSchema#string

Tanya Parish

http://www.w3.org/2001/XMLSchema#string

Theresa O'Malley

http://www.w3.org/2001/XMLSchema#string

Thierry Masquelin

http://www.w3.org/2001/XMLSchema#string

Torey Alling

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB

A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain

Bactericidal activity of an imidazo[1, 2-a]pyridine using a mouse M. tuberculosis infection model

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.

Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.

Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories.

Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis.

P31

scholarly article

P356

10.1128/AAC.02439-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heather A Wescott

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29632008

http://www.w3.org/2001/XMLSchema#string

P932

5971599

http://www.w3.org/2001/XMLSchema#string